Avidity Partners Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,000
| Closed | -$868K | – | 74 |
|
|
2025
Q1 | $868K | Buy |
+23,000
| New | +$868K | 0.17% | 59 |
|
|
2024
Q3 | – | Sell |
-284,000
| Closed | -$21.4M | – | 98 |
|
|
2024
Q2 | $21.4M | Hold |
284,000
| – | – | 0.91% | 45 |
|
|
2024
Q1 | $19.4M | Sell |
284,000
-286,137
| -50% | -$19.5M | 0.63% | 49 |
|
|
2023
Q4 | $35.8M | Sell |
570,137
-186,028
| -25% | -$11.7M | 1.3% | 37 |
|
|
2023
Q3 | $38.5M | Sell |
756,165
-118,835
| -14% | -$6.06M | 1.55% | 29 |
|
|
2023
Q2 | $43.7M | Buy |
875,000
+365,000
| +72% | +$18.2M | 1.53% | 24 |
|
|
2023
Q1 | $19.1M | Sell |
510,000
-1,105,400
| -68% | -$41.4M | 0.63% | 52 |
|
|
2022
Q4 | $77.5M | Buy |
1,615,400
+986,700
| +157% | +$47.3M | 1.68% | 20 |
|
|
2022
Q3 | $15.1M | Buy |
+628,700
| New | +$15.1M | 0.31% | 59 |
|